Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.

Front Immunol · 2022 · PMC9382657 · PMID 35990696

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Both PFS and OS of GBM patients with high PRRS showed a trend toward improved response compared with the low-PRRS group.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

However, these differences did not reach statistical significance, partially due to the limited sample size ( Figure 8F, G ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.